Immunogen reported $2.15M in Cost of Sales for its fiscal quarter ending in September of 2023.

Cost Of Sales Change Date
AstraZeneca USD 2.06B 91M Sep/2023
Roche Holding CHF 7.62B 1.33B Jun/2023